| 体内研究: |
对啮齿动物的研究表明,Pericyazine 能够增强乙醚和己巴比妥麻醉作用以及吗啡镇痛作用。它还具有体温过低的活性并抑制小鼠的自发运动活动。在毫克效力的基础上,Pericyazine 在增强巴比妥酸盐麻醉试验和阻断大鼠的条件性回避方面比氯丙嗪更有效。Pericyazine 在小鼠和大鼠中表现出类似于甲氨蝶呤的镇痛特性,并在小鼠和犬中产生肾上腺素能阻断作用。 |
| 参考文献: |
1. Morley KC, et al. Pericyazine in the treatment of cannabis dependence in general practice: a naturalistic pilot trial. Subst Abuse Rehabil. 2012 May 28;3:43-7. 2. Farde L, et al. D1- and D2-dopamine receptor occupancy during treatment with conventional and atypicalneuroleptics. Psychopharmacology (Berl). 1989;99 Suppl:S28-31. 3. Divac N, et al. Second-generation antipsychotics and extrapyramidal adverse effects. Biomed Res Int. 2014;2014:656370. 4. Cai HL, et al. A sensitive LC-MS/MS method for analysis of pericyazine in presence of 7-hydroxypericyazine and pericyazine sulphoxide in human plasma and its application to a comparative bioequivalence study in Chinese healthy volunteers. J Pharm Biomed Anal. 2017;135:67‐74. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.736 ml |
13.68 ml |
27.361 ml |
| 5 mM |
0.547 ml |
2.736 ml |
5.472 ml |
| 10 mM |
0.274 ml |
1.368 ml |
2.736 ml |
| 50 mM |
0.055 ml |
0.274 ml |
0.547 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |